Trademark Overview
On Tuesday, July 2, 2024, a trademark application was filed for IMMUNOPOLIS with the United States Patent and Trademark Office. The USPTO has given the IMMUNOPOLIS trademark a serial number of 98629710. The federal status of this trademark filing is NEW APPLICATION - RECORD INITIALIZED NOT ASSIGNED TO EXAMINER as of Tuesday, July 2, 2024. The IMMUNOPOLIS trademark is filed in the Pharmaceutical Products, Computer & Software Services & Scientific Services, and Medical & Beauty Services & Agricultural Services categories with the following description:
Pharmaceutical products for the prevention and treatment of cancer, infectious diseases, and immunological diseases; Vaccines; Adjuvants for medical purposes; Chemical reagents used for medical or veterinary purposes; Biochemical reagents used for medical or veterinary purposes; Macromolecules, namely, nucleic acid sequences and protein supplements, used for medical and veterinary purposes
Medical services, namely, providing therapies for treating cancer, infectious diseases and immunological diseases; Veterinary services, namely, providing therapies for treating cancer, infectious diseases, and immunological diseases; Medical and pharmaceutical consultation; Medical diagnostic testing, monitoring and reporting services; Genetic testing for medical purposes
Medical and scientific research in the field of treatment of immunological diseases, cancer treatment, and treatment of infectious diseases; Providing medical and scientific research information, consultancy, and advisory services in the field of pharmaceuticals and clinical trials; Compiling data for medical and scientific research, clinical trials, and drug admission